|
|
| | GSK-7975A Basic information |
| Product Name: | GSK-7975A | | Synonyms: | GSK-7975A;2,6-Difluoro-N-(1-{[4-hydroxy-2-(trifluoromethyl)phenyl]methyl} 1H-pyrazol-3-yl)benzamide;2,6-Difluoro-N-(1-(4-hydroxy-2-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide;Benzamide, 2,6-difluoro-N-[1-[[4-hydroxy-2-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-3-yl]-;Ca channels,Calcium Channel,GSK 7975A,inhibit,Inhibitor,Ca2+ channels,GSK7975A,GSK-7975A | | CAS: | 1253186-56-9 | | MF: | C18H12F5N3O2 | | MW: | 397.3 | | EINECS: | | | Product Categories: | | | Mol File: | 1253186-56-9.mol |  |
| | GSK-7975A Chemical Properties |
| Boiling point | 462.2±45.0 °C(Predicted) | | density | 1.46±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO:90.0(Max Conc. mg/mL);226.53(Max Conc. mM) | | pka | 8.82±0.20(Predicted) | | form | Solid | | color | White to off-white |
| | GSK-7975A Usage And Synthesis |
| | GSK-7975A Preparation Products And Raw materials |
|